A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
Public ClinicalTrials.gov record NCT05110976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase I, Randomised, Blinded, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8630 in Healthy Adult Subjects (Part A) and Adults With Asthma on Medium to High Dose Inhaled Corticosteroids and Long-acting Beta-agonists (Part B)
Study identification
- NCT ID
- NCT05110976
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Interventions
- AZD8630 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 15, 2021
- Primary completion
- Aug 1, 2023
- Completion
- Aug 1, 2023
- Last update posted
- Aug 29, 2023
2021 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Tempe | Arizona | 85283 | — |
| Research Site | Bakersfield | California | 93301 | — |
| Research Site | Glendale | California | 91206 | — |
| Research Site | San Jose | California | 95117 | — |
| Research Site | Homestead | Florida | 33030 | — |
| Research Site | Miami | Florida | 33122 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Miami | Florida | 33155 | — |
| Research Site | Miami | Florida | 33173 | — |
| Research Site | Miami | Florida | 33175 | — |
| Research Site | Boise | Idaho | 83706 | — |
| Research Site | White Marsh | Maryland | 21162 | — |
| Research Site | North Dartmouth | Massachusetts | 02747 | — |
| Research Site | Ann Arbor | Michigan | 48105 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Toledo | Ohio | 43617 | — |
| Research Site | Portland | Oregon | 97202 | — |
| Research Site | El Paso | Texas | 79903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05110976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05110976 live on ClinicalTrials.gov.